Allergy Therapeutics plc (AIM:AGY)
London · Delayed Price · Currency is GBP · Price in GBX 8.10
-0.25 (-3.00%)
Sep 9, 2025, 2:07 PM GMT+1
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 398.00 million as of September 9, 2025. Its market cap has increased by 98.81% in one year.
Market Cap
398.00M
Enterprise Value
420.84M
Revenue
55.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.10
Market Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 398.00M, an increase of 1,201.95%. That is a compound annual growth rate of 13.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 398.00M | 28.46% |
| Dec 31, 2024 | 309.82M | 160.00% |
| Dec 29, 2023 | 119.16M | 180.75% |
| Dec 30, 2022 | 42.44M | -79.49% |
| Dec 31, 2021 | 206.98M | 94.57% |
| Dec 31, 2020 | 106.38M | 63.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |